BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15077037)

  • 21. Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody.
    Pierson RN; Chang AC; Blum MG; Blair KS; Scott MA; Atkinson JB; Collins BJ; Zhang JP; Thomas DW; Burkly LC; Miller GG
    Transplantation; 1999 Dec; 68(11):1800-5. PubMed ID: 10609959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates.
    Xu H; Tadaki DK; Elster EA; Burkly LC; Berning JD; Cruzata F; Kampen RL; Montgomery SP; Patterson NB; Harlan DM; Kirk AD
    Transplantation; 2002 Oct; 74(7):940-3. PubMed ID: 12394834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
    Xu H; Elster EA; Blair PJ; Burkly LC; Tadaki DK; Harlan DM; Kirk AD
    Am J Transplant; 2003 Nov; 3(11):1350-4. PubMed ID: 14525594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
    Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y; Boisgerault F; Benichou G; Dana MR
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
    Xu H; Elster E; Batty D; Berning J; Burkly L; Kampen R; Swanson S; Tadaki D; Harlan D; Kirk A
    Transplant Proc; 2001; 33(1-2):223-4. PubMed ID: 11266788
    [No Abstract]   [Full Text] [Related]  

  • 27. Primate renal transplants using immunotoxin.
    Knechtle SJ; Fechner JH; Dong Y; Stavrou S; Neville DM; Oberley T; Buckley P; Armstrong N; Rusterholz K; Hong X; Tsuchida M; Hamawy MM
    Surgery; 1998 Aug; 124(2):438-46; discussion 446-7. PubMed ID: 9706169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
    Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.
    Thomas JM; Neville DM; Contreras JL; Eckhoff DE; Meng G; Lobashevsky AL; Wang PX; Huang ZQ; Verbanac KM; Haisch CE; Thomas FT
    Transplantation; 1997 Jul; 64(1):124-35. PubMed ID: 9233712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys.
    Jonker M; Ringers J; Ossevoort MA; Slingerland W; van den Hout Y; Haanstra K; Wubben J; Kuhn E; Friend P; Calne R
    Transplantation; 2002 Mar; 73(6):874-80. PubMed ID: 11923686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Split tolerance induced by immunotoxin in a rhesus kidney allograft model.
    Fechner JH; Vargo DJ; Geissler EK; Graeb C; Wang J; Hanaway MJ; Watkins DI; Piekarczyk M; Neville DM; Knechtle SJ
    Transplantation; 1997 May; 63(9):1339-45. PubMed ID: 9158030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune molecular profiling of whole blood drawn from a non-human primate cardiac xenograft model treated with anti-CD154 monoclonal antibodies.
    Ock SA; Oh KB; Hwang S; Yun IJ; Ahn C; Chee HK; Kim H; Ullah I; Im GS; Park EW
    Xenotransplantation; 2018 Sep; 25(5):e12392. PubMed ID: 29582477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
    Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms.
    Azimzadeh AM; Pfeiffer S; Wu G; Schröder C; Zorn GL; Kelishadi SS; Ozkaynak E; Kehry M; Atkinson JB; Miller GG; Pierson RN
    Transplantation; 2006 Jan; 81(2):255-64. PubMed ID: 16436970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.
    Kenyon NS; Chatzipetrou M; Masetti M; Ranuncoli A; Oliveira M; Wagner JL; Kirk AD; Harlan DM; Burkly LC; Ricordi C
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8132-7. PubMed ID: 10393960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
    Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.